Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.350
+0.180 (5.68%)
At close: May 12, 2025, 4:00 PM
3.490
+0.140 (4.18%)
After-hours: May 12, 2025, 7:05 PM EDT
Voyager Therapeutics Market Cap
Voyager Therapeutics has a market cap or net worth of $185.38 million as of May 12, 2025. Its market cap has decreased by -57.58% in one year.
Market Cap
185.38M
Enterprise Value
-67.75M
1-Year Change
-57.58%
Ranking
Category
Stock Price
$3.35
Market Cap Chart
Since May 13, 2020, Voyager Therapeutics's market cap has decreased from $426.95M to $185.38M, a decrease of -56.58%. That is a compound annual growth rate of -15.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 183.78M | -43.97% |
| Dec 31, 2024 | 328.02M | -11.64% |
| Dec 29, 2023 | 371.22M | 57.87% |
| Dec 30, 2022 | 235.14M | 128.04% |
| Dec 31, 2021 | 103.11M | -61.36% |
| Dec 31, 2020 | 266.88M | -37.49% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |